pfizer glp-1 news scraps daily weight loss pill danuglipron after a liver injury Pfizer joining GLP-1 race: How

PubMed Central , Accessed 23 Apr

This combination of effects makes it easier for you to stick to a reduced-calorie diet and, in turn, achieve significant and sustained weight loss

Preclinical studies have revealed their ability to reduce neuroinflammation, reduce tau phosphorylation, reduce amyloid deposition, and improve memory formation, all of which are implicated in the progression of neurodegeneration

Perhaps the most crucial data point for long-term adherence is side effect management

Astrup, A

Encouragingly, there may now be a better solution than any of these three hacks. Novo Nordisks Wegovy pill, an oral form of semaglutide, was FDA-approved in December 2025 and launched in January 2026